» Authors » Gary W Moore

Gary W Moore

Explore the profile of Gary W Moore including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 62
Citations 533
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Verbruggen B, Binder N, van Velp P, Polenewen R, Knobl P, Sobas F, et al.
J Thromb Haemost . 2024 Jul; 22(10):2745-2751. PMID: 38992344
Background: Factor (F)VIII inhibitors are measured using labor- and resource-expensive Nijmegen or Bethesda assays, which lack sensitivity for low-titer inhibitors and show high variations in quality surveys, mainly because of...
2.
Moore G
Semin Thromb Hemost . 2024 May; 50(8):1131-1152. PMID: 38733983
Although inherited thrombophilias are lifelong risk factors for a first thrombotic episode, progression to thrombosis is multifactorial and not all individuals with inherited thrombophilia develop thrombosis in their lifetimes. Consequently,...
3.
Vandevelde A, Gris J, Moore G, Musial J, Zuily S, Wahl D, et al.
J Thromb Haemost . 2024 May; 22(8):2345-2362. PMID: 38704123
Background: Improving harmonization of the clinical interpretation of anticardiolipin (aCL) and anti-β2-glycoprotein I (aβ2GPI) antibodies immunoglobulin G (IgG)/immunoglobulin M (IgM) in the diagnosis of antiphospholipid syndrome (APS) is desirable. Likelihood...
4.
Moore G, Platton S, Yartey N, Foxton E, White D, MacDonald S
Int J Lab Hematol . 2024 Feb; 46(3):538-545. PMID: 38303489
Introduction: Dilute Russell's viper venom time (dRVVT) and activated partial thromboplastin time (APTT) are the mainstay assays in lupus anticoagulant (LA) detection yet they have limitations, particularly in relation to...
5.
Gosselin R, Moore G, Kershaw G, Montalvao S, Adcock D
Arch Pathol Lab Med . 2023 Nov; 148(8):880-889. PMID: 38031817
Context.—: The prothrombin time (PT) and activated partial thromboplastin time (APTT) are screening tests used to detect congenital or acquired bleeding disorders. An unexpected PT and/or APTT prolongation is often...
6.
7.
Moore G, Foxton E, Platton S, Yartey N, White D, MacDonald S
J Thromb Haemost . 2023 Aug; 21(12):3539-3546. PMID: 37597725
Background: Triple positivity for all 3 criteria antiphospholipid antibodies confers high risk of symptom development in carriers, and recurrence in antiphospholipid syndrome (APS). Most triple-positivity studies report lupus anticoagulant (LA)...
8.
Moore G, Vetr H, Binder N
Methods Mol Biol . 2023 May; 2663:549-565. PMID: 37204736
A finding of an ADAMTS13 (a disintegrin-like and metalloprotease with thrombospondin type 1 motif, member 13) activity level of <10% of normal is usually sufficient to distinguish thrombotic thrombocytopenic purpura...
9.
Moore G, Llusa M, Griffiths M, Binder N
Methods Mol Biol . 2023 May; 2663:533-547. PMID: 37204735
Accurate estimation of ADAMTS13 (a disintegrin-like and metalloprotease with thrombospondin type 1 motif, member 13) activity level is crucial in the diagnostic setting of differentiation between thrombotic thrombocytopenic purpura (TTP)...
10.
Moore G, Griffiths M, Binder N
Methods Mol Biol . 2023 May; 2663:523-531. PMID: 37204734
Accurate estimation of ADAMTS13 (a disintegrin-like and metalloprotease with thrombospondin type 1 motif, member 13) activity level is necessary for diagnosis and management of thrombotic microangiopathies (TMA). In particular, it...